Braveheart Bio Funding: $190M Raised, Series A (2025)

Braveheart Bio is based in San Francisco. It has raised $190M in total funding. Latest round: Series A. Backed by Forbion, RA Capital, Andreessen Horowitz.

Braveheart Bio funding overview

Braveheart Bio is based in San Francisco. Braveheart Bio has raised $190M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in November 2025. The round record for Braveheart Bio runs through 2025; nothing later has been disclosed. Investors on record include Forbion, RA Capital, Andreessen Horowitz, Enavate Sciences, Frazier Life Sciences, OrbiMed. 6 distinct backers are named across the disclosed rounds.

Braveheart Bio at a glance

Total raised
$190M
Latest round
Series A
Latest round date
November 2025
Headquarters
San Francisco
Notable investors
Forbion, RA Capital, Andreessen Horowitz, Enavate Sciences, Frazier Life Sciences, OrbiMed

Frequently asked about Braveheart Bio funding

How much has Braveheart Bio raised?
Braveheart Bio has raised $190M in total disclosed funding across the rounds on record.
Who has invested in Braveheart Bio?
Forbion, RA Capital, Andreessen Horowitz, Enavate Sciences, Frazier Life Sciences, OrbiMed are named among the investors backing Braveheart Bio.
What was the latest Braveheart Bio funding round?
The most recent disclosed round is a Series A, announced in November 2025.
Where is Braveheart Bio based?
Braveheart Bio is based in San Francisco.
When did Braveheart Bio last raise?
The last disclosed Braveheart Bio round closed in November 2025 at Series A.

Totals shown for Braveheart Bio aggregate every disclosed round on file. To see how that compares, browse the companies in San Francisco and the investors behind them below.

Companies related to Braveheart Bio (36)

Browse related funding lists (10)

Company funding database · Investor directory · Founder database · Mega-rounds 2026